Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
6,010.00
-6.00(-0.10%)
Dow Futures
44,072.00
-36.00(-0.08%)
Nasdaq Futures
21,118.50
-41.00(-0.19%)
Russell 2000 Futures
2,378.40
-4.30(-0.18%)
Crude Oil
68.19
-0.24(-0.35%)
Gold
2,565.10
-21.40(-0.83%)

Eledon Pharmaceuticals, Inc. (ELDN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

4.2700

-0.5500

(-11.41%)

At close: 04:00PM EST

4.2700

0.00

(0.00%)

After hours:

04:57PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	289.74M
Enterprise Value	206.78M
Trailing P/E	10.78
Forward P/E	5.39
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	1.31
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	0.84

Trading Information

Stock Price History

Beta (5Y Monthly)	0.77
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	5.5400
52 Week Low ³	1.1100
50-Day Moving Average ³	3.1663
200-Day Moving Average ³	2.5328

Share Statistics

Avg Vol (3 month) ³	341.86k
Avg Vol (10 day) ³	795.6k
Shares Outstanding ⁵	59.74M
Implied Shares Outstanding ⁶	N/A
Float ⁸	30.73M
% Held by Insiders ¹	0.05%
% Held by Institutions ¹	44.94%
Shares Short (Oct 31, 2024) ⁴	960.55k
Short Ratio (Oct 31, 2024) ⁴	1.45
Short % of Float (Oct 31, 2024) ⁴	1.80%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	1.61%
Shares Short (prior month Sep 30, 2024) ⁴	118.63k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Oct 05, 2020
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:18
Last Split Date ³	Oct 05, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-25.80%
Return on Equity (ttm)	-237.39%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	-108.54M
Diluted EPS (ttm)	0.4000
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	83.61M
Total Cash Per Share (mrq)	2.11
Total Debt (mrq)	655k
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	14.48
Book Value Per Share (mrq)	0.30

Cash Flow Statement

Operating Cash Flow (ttm)	-37.9M
Levered Free Cash Flow (ttm)	-20.86M